We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 5 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 13 actions collected · 5 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 04. 22. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2026. 03. 16. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2026. 01. 27. | HC Wainwright & Co. | — | Initiate coverage | — → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 12. 09. | JP Morgan | — | Maintain | Neutral → Neutral | — | JP Morgan: Neutral |
| 2025. 09. 04. | JP Morgan | — | Maintain | Neutral → Neutral | — | JP Morgan: Neutral |
| 2025. 03. 11. | LifeSci Capital | — | Initiate coverage | — → Outperform | — | LifeSci Capital: Outperform |
| 2023. 12. 06. | JP Morgan | — | Maintain | Neutral → Neutral | — | JP Morgan: Neutral |
| 2022. 08. 29. | SVB Leerink | — | Downgrade | Outperform → Market Perform | — | SVB Leerink: Outperform → Market Perform |
| 2022. 05. 25. | Credit Suisse | — | Upgrade | Underperform → Neutral | — | Credit Suisse: Underperform → Neutral |
| 2022. 04. 27. | SVB Leerink | — | Maintain | — → Outperform | — | SVB Leerink: Outperform |
| 2022. 01. 14. | SVB Leerink | — | Maintain | — → Outperform | — | SVB Leerink: Outperform |
| 2021. 08. 27. | SVB Leerink | — | Maintain | — → Outperform | — | SVB Leerink: Outperform |
| 2021. 07. 13. | Cowen & Co. | — | Initiate coverage | — → Outperform | — | Cowen & Co.: Outperform |